The Garvan-Weizmann Partnership
The collaborative endeavour between the Garvan Institute of Medical Research and the Weizmann Institute of Science is an international association that harnesses the synergistic strengths of two world-class research institutes.
Through joint programs and cutting-edge technologies, Garvan and Weizmann are together uncovering entirely new insights into cancer, immune diseases, metabolic disorders and other conditions.
We are delighted to update you about the groundbreaking research already underway through the Garvan-Weizmann partnership, and to seek your support for this exciting collaborative endeavour.
The Garvan-Weizmann partnership is an organisation-wide collaboration between two leading institutes with complementary research strengths.
The construction of the Garvan-Weizmann Centre for Cellular Genomics and solidifying of the partnership was enabled through a $5 million commitment from the NSW Government, matched by visionary donors.
However, it is the research being produced in the Centre, and through the partnership, that will shape the future. Further funding will make possible the cutting-edge collaborative research projects that are driven by the Centre’s technologies and expertise.
Before our partnership was formalised, there were already a number of research teams at the Garvan and Weizmann Institutes working together. Now, we are seeing the Garvan-Weizmann partnership strengthen and accelerate those collaborations. The partnership has fostered inventive projects that seek to understand key aspects of melanoma, breast cancer, the spread of cancers to bone, cancer immunotherapy, immunology and diabetes – and ultimately to affect outcomes for individuals with these diseases.
Importantly, the Centre’s facilities are will be available to researchers beyond those at Garvan and Weizmann, kick-starting an era of rapid advances in the cell-by-cell understanding of how our genes function in health and disease.
Weizmann Institute of Science
The Weizmann Institute of Science (Rehovot, Israel) is one of the world’s leading multidisciplinary basic research institutions in the natural sciences. The Weizmann Institute has a long history of investigation and discovery rooted in a mission of advancing science for the benefit of humanity. In parallel, it educates a substantial proportion of Israel’s scientific leadership and advances science literacy in schools and among the public. It comprises 250 experimental and theoretical research groups across five faculties – Biology, Biochemistry, Chemistry, Mathematics and Computer Science, and Physics.
Garvan Institute of Medical Research
In 2012, Garvan established the Kinghorn Centre for Clinical Genomics, Australia's first purpose-built facility for undertaking clinical-grade genome sequencing. In 2016, Garvan launched Genome.One, Australia's first clinical whole-genome sequencing service.